Recombinant Human EphB6 Protein，His

EphB6 is a member of the Eph receptor tyrosine kinase family, which plays a critical role in cell signaling processes such as cell positioning, migration, and differentiation during development and tissue homeostasis. Unlike its EphB family counterparts, EphB6 is characterized as a "truncated" receptor, lacking a functional kinase domain that impairs its ability to initiate downstream signaling cascades upon ligand binding. This unique feature positions EphB6 as a potential negative regulator of Eph receptor signaling, suggesting it may play a crucial role in modulating the activity of other Eph receptors in various biological contexts. Research has indicated that EphB6 is involved in several physiological and pathological processes, including tumorigenesis, neural development, and immune responses. Its expression patterns are notably altered in certain cancers, indicating its potential as a biomarker and therapeutic target. Given the complexity of the Eph receptor signaling network and the unique properties of EphB6, recombinant EphB6 protein studies aim to elucidate its functional roles and interactions with ligands and other receptors. This research might provide insights into the mechanisms of Eph receptor signaling modulation, helping to define the therapeutic potential of targeting EphB6 in diseases where its regulatory functions are disrupted. Thus, the investigation of EphB6 recombinant proteins is vital for understanding its biological significance and potential applications in clinical settings, particularly in cancer biology and therapeutic interventions.